Vemzatatug is a humanized IgG1κ monoclonal antibody inhibitor targeting GPRC5D. Vemzatatug has an antitumor activity. Vemzatatug can be used for cancers like multiple myeloma (MM) research.
CAS号
3035714-52-1
运输条件
Room temperature in continental US; may vary elsewhere.